cdmo.directory
← Compare landing

Clearsynth vs HAS Healthcare Advanced Synthesis SA

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/clearsynth/hashealthcare

CategoryClearsynthHAS Healthcare Advanced Synthesis SA
Listed sitecdmocdmo
SummaryClearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.HAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.
Services
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
Modalities
  • Small Molecule
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
IndicationsData not yet provided.
  • Oncology
Locations
  • Corporate Headquarters, Mumbai, Maharashtra, India
  • Regional Office, Canada, Canada
  • Regional Office, USA, United States
  • Biasca, Biasca, Switzerland
Certifications
  • ISO · Identifier: ISO 17025
  • ISO · Identifier: ISO 17034
  • ISO · Identifier: ISO 9001:2015
  • DSIR · Identifier: DSIR Recognized
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.